Division News

Duke stem cell patients celebrate 20 years of reunions

For the last 20 years, Duke Bone Marrow Transplant program patients have been holding annual reunions. The first reunion, held in 1996, was attended by 20 attendees. This year's celebration, held in September, was attended by 400.

Researchers identify genetic drivers of most common form of lymphoma

An international research effort led by Duke Cancer Institute scientists has been working to better understand the genetic underpinnings of diffuse large B cell lymphoma and how those genes might play a role in patients’ responses to therapies. The findings were published this week in the journal Cell.

Harnessing genetics to disrupt blood cancers

To better understand blood cancers, Sandeep Davé, MD, MBA, MS, hunts down variation in the DNA sequences important to those cancers. One international project he launched is deploying comparative genetics to better classify the more than 100 blood cancers.

But the research never stops there.

Funding opp: Duke-UNC Immunotherapy Training Grant

The Duke-UNC Immunotherapy Training Grant (DUNC-IMTG) is a NCI-funded T32 training program at the University of North Carolina at Chapel Hill and Duke University that trains postdoctoral fellows in pre-clinical and/or clinical research focusing on tumor immunotherapy and/or stem cell transplantation immunology. Applications for 2017-18 are due at 5 p.m. on Aug. 11, 2017.